News

Exclusive - GPs want obesity out of framework

30-May-07

Half of GPs want obesity to be scrapped from the quality framework, a GP survey has revealed.

The survey of 155 GPs showed that 47 per cent of GPs wanted obesity to be dropped. A quarter wanted learning difficulties and chronic kidney disease removed from the framework. Twelve per cent rejected the smoking indicators.

Scottish LMCs voted in April 2007 for obesity to be dropped from the quality framework because it is a lifestyle issue.

The survey also highlighted that 34 per cent of GPs wanted changes to the way in which the quality framework deals with obesity, if it remains an indicator.

Hertfordshire GP Dr David Haslam, clinical director of the National Obesity Forum, described the obesity domain, worth eight points and introduced in 2006/7, as ‘worse than useless.'

'I sympathise with the GPs who want obesity to be dropped, because the current indicator is of no clinical benefit at all. All it does is elevate all obese patients to the same status,' he said.

GPC deputy chairman Dr Laurence Buckman said that the indicator for obesity was a meaningless device that was included in the quality framework simply to please politicians.

'It is the only indicator in the quality framework that is not supported by clinical evidence,' he said.

Dr Haslam said that it was essential that obesity remained in the quality framework.

'We need to be screening the patients on the obesity register for diabetes, hypertension, stroke and heart disease,' he said.

'Patients can then be moved from the obesity register to other clinical registers, such as diabetes.'

'There is a 100-fold increased risk of diabetes in individuals who have a BMI of 35 and over.'

The survey found that GPs believed that obesity was a social problem and not a medical one that GPs could effectively treat.

Dr Haslam, however, disagreed saying that it was important for GPs to be involved in obesity so that they could pick up other conditions.

'It is important for our sanity; we don't want an epidemic of obesity on our hands,' he added.

The survey also showed that a quarter of GPs wanted depression, worth 33 points, to be dropped from the quality framework, with many unhappy about the validity of the questionnaire used to detect it.

Dr Ian Walton, chairman of Primary Care Mental Health and Education (PRIMHE) and a GP in Sandwell, West Midlands,

said that it was notoriously difficult to measure depression consistently and agreed that the tools that GPs had to do this were not good enough.

But chief executive of PRIMHE Dr Chris Manning said: 'Take depression out of the quality framework and you take out some of the most crucial work that GPs need to be doing.'

sanjay.tanday@haymarket.com

What do you think? Comment below or email us at GPletters@haymarket.com  

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Journals club - HPV vaccine

Curriculum statement 5. Healthy people: promoting health and preventing disease. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week